PartsTable
Technical Data Sheet
Download PDF

NDC00182-1400-89 — THEOPHYLLINE EXTENDED-RELEASE TA

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00182-1400-89: THEOPHYLLINE EXTENDED-RELEASE TA.

THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include features_provided: UNIT DOSE, primary_container_type: STRIP, therapeutic_equivalent: THEO-DUR BY KEY PHARM, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG.

This part is cataloged in the U.S. Government catalog under NSN 6505-01-073-1552, indicating validated use in U.S. government and defense logistics supply chains.

Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00182-1400-89
NSN: 6505-01-073-1552
FSC: 6505 — Drugs and Biologicals
CAGE: 0LXM4 — IVAX (USA)
SPECIFICATIONS
features_providedUNIT DOSE
primary_container_typeSTRIP
therapeutic_equivalentTHEO-DUR BY KEY PHARM
primary_container_content_quantity100.000 TABLETS
active_medicament_medicinal_strength300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyTHEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG
NSN6505-01-073-1552
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available THEOPHYLLINE EXTENDED-RELEASE TA TITLE COMPONENT PN NDC00182-1400-89 MFR THEOPHYLLINE EXTENDED-
KEY FEATURES
•
THERAPEUTIC EQUIVALENT: THEO-DUR BY KEY PHARM
•
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
•
FEATURES PROVIDED: UNIT DOSE
•
PRIMARY CONTAINER TYPE: STRIP
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
TECHNICAL CHARACTERISTICS
THERAPEUTIC EQUIVALENTTHEO-DUR BY KEY PHARM
PRIMARY CONTAINER CONTENT QUANTITY100.000 TABLETS
FEATURES PROVIDEDUNIT DOSE
PRIMARY CONTAINER TYPESTRIP
PART NAME ASSIGNED BY CONTROLLING AGENCYTHEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG I.S. 100S PG
ACTIVE MEDICAMENT MEDICINAL STRENGTH300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 8
THEO-DURReference document
Same NSN cross-reference
Reference document — Secondary reference
NDC00258-3581-01Reference document
Same NSN cross-reference
Reference document — Secondary reference
NDC00456-4330-01Same NSN cross-reference
Same NSN cross-reference
Also cataloged under this NSN
NDC00603-5946-21Reference document
Same NSN cross-reference
Reference document — Secondary reference
NDC00904-1612-61Same NSN cross-reference
Same NSN cross-reference
Also cataloged under this NSN
NDC61570-0019-01Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusCancelled· U.S. Government catalog
No demilitarization required
Ready to buy NDC00182-1400-89?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00182-1400-89?
NDC00182-1400-89 is a THEOPHYLLINE EXTENDED-RELEASE TA.
What parts can replace NDC00182-1400-89?
There are 8 known substitutes for NDC00182-1400-89: THEO-DUR, NDC00258-3581-01, NDC00456-4330-01 and 5 more. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00182-1400-89?
NDC00182-1400-89 is cataloged in the U.S. Government catalog under NSN 6505-01-073-1552. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00182-1400-89